Stockscreener 앱 받기
131.56
3.75%
4.975
전일 마감가:
$126.59
열려 있는:
$125.94
하루 거래량:
928.87K
Relative Volume:
0.62
시가총액:
$14.68B
수익:
$2.90B
순이익/손실:
$239.11M
주가수익비율:
62.36
EPS:
2.1097
순현금흐름:
$492.62M
1주 성능:
+3.95%
1개월 성능:
+16.69%
6개월 성능:
+37.39%
1년 성능:
+49.47%
1일 변동 폭
$125.94
$131.75
1주일 범위
$125.46
$131.75
52주 변동 폭
$81.22
$131.75
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IQV, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
131.52 | 13.85B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
608.95 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
210.09 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
323.12 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
265.21 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
151.18 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Revvity stock trades around $123 as investors weigh latest earnings and analyst targets - Ad-hoc-news.de
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Revvity (RVTY) Stock Is Up Today - Quiver Quantitative
Revvity stock hits new 52-week high as gains extend - Ad-hoc-news.de
Revvity stock hits 52-week high at 122.26 USD - Investing.com
Revvity stock hits 52-week high at 122.26 USD By Investing.com - Investing.com India
Revvity Inc (RVTY) Shares Surge 5.0% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Revvity stock edges lower as SuperFlex launch and Q2 earnings shape valuation debate - Ad-hoc-news.de
Revvity Inc (RVTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity (NYSE: RVTY) executive gifts 27,785 shares to trust - Stock Titan
Revvity (NYSE:RVTY) Gains Attention After SuperFlex Launch - Kalkine Media
Revvity CEO Prahlad Singh Transfers Over 67,000 Shares to Family Trusts in Gift Transactions - Kalkine Media
Revvity (NYSE: RVTY) CEO shifts stock into family trusts at $0 - Stock Titan
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with Modest Upside and Resilient Performance - DirectorsTalk Interviews
Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold" - MarketBeat
T. Rowe Price (RVTY) reports 16.4% Revvity stake, 18.3M shares under control - Stock Titan
T. Rowe Price Associates (RVTY) discloses 5.0% beneficial stake in Revvity - Stock Titan
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs - Zacks Investment Research
Revvity (NYSE:RVTY) Hits New 12-Month HighWhat's Next? - MarketBeat
Revvyty Inc stock hits 52-week high at 118.34 USD By Investing.com - Investing.com South Africa
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
Taylor Farms Recall Puts Food Safety Stocks On Retail Investors Radar - sahmcapital.com
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - Stock Titan
Revvity (RVTY) Q2 2026 Earnings Call Transcript - aol.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation With A 5.59% Upside - DirectorsTalk Interviews
Bank of America Corp DE Increases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Q2 Earnings Call Highlights - Yahoo Finance
Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - webull.com
Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (0KHE) Q3 2022 Earnings ReportResults, Call & Slides - tipranks.com
REVVITY, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $100 - webull.com
Revvity (NYSE:RVTY) Rating Increased to Hold at Zacks Research - marketbeat.com
Arrowstreet Capital Limited Partnership Sells 328,169 Shares of Revvity Inc. $RVTY - MarketBeat
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY? - Yahoo Finance
Stifel raises Revvity stock price target to $110 on earnings beat - Investing.com
REVVITY, INC. : JP MORGAN RAISES TARGET PRICE TO $110 FROM $90 - Moomoo
Revvity posts solid Q2 2026 earnings growth - The Globe and Mail
Amundi Sells 32,858 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.81%
0.80%
자본화:
|
볼륨(24시간):